Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients
26 August 2018 (08:30 - 12:30)
Organised by:
Abstract
About the speaker

Department of Cardiology, Lund (Sweden)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
26 August 2018
08:30 CET
